BACKGROUND Endometrial hyperplasia (EH) is a uterine pathology representing a
spectrum of morphological endometrial alterations. It is predominantly characterized by an …

Endometrial hyperplasia (EH) comprises a spectrum of changes in the endometrium ranging
from a slightly disordered pattern that exaggerates the alterations seen in the late …

This 2004 volume in the World Health Organization series on histologic and genetic ty**
of human tumors covers tumors of the kidney, urinary system, prostate, testis and …

Background: PTEN tumor suppressor gene mutations are the most frequent genetic lesions
in endometrial adenocarcinomas of the endometrioid subtype. Testing the hypothesis that …

STUDY QUESTION How should fertility-sparing treatment of patients with endometrial
carcinoma be performed? SUMMARY ANSWER Forty-eight recommendations were …

BACKGROUND Adenocarcinoma of the endometrium is the most common gynecologic
malignancy in the United States, accounting for approximately 36,000 diagnoses of invasive …

Background To inform treatment decisions in women diagnosed with endometrial
hyperplasia, quantification of the potential for concurrent endometrial cancer and the future …

OBJECTIVE: To systematically review and summarize the medical literature regarding the
association of menopausal status, uterine bleeding, and polyp size and risk of malignancy …

The diagnosis of precancerous lesions of the endometrium remains unstandardized
because existing World Health Organization classification categories do not correspond to …

OBJECTIVE: The objective of the study was to estimate the age-specific incidence of
endometrial hyperplasia: simple, complex, and atypical, in order of increasing likelihood of …